Table 3.
HLH protein diseases and mechanisms
| Disease | Affected organ or tissue |
HLH protein | evidence | Process affected |
|---|---|---|---|---|
| Pitt-Hopkins syndrome | Brain, face | E2-2 | Human mutation | Differentiation? Cell cycle? Neuronal morphogenesis? |
| Fuchs corneal dystrophy | eye | E2-2 | Human gene association | senescence? |
| schizophrenia | brain | E2-2 | Human gene association | Differentiation? Cell cycle? Neuronal morphogenesis? |
| Rett syndrome | brain | E2A, ID1-4 | Gene expression | Differentiation? Cell cycle? Neuronal morphogenesis? |
| atherosclerosis | arteries | E2A, ID3 | Human, mouse gene association | Differentiation? |
| Diamond Blackfan anemia | Bone marrow | E2A, E2-2, ID2 | Gene expression | Differentiation? |
| Diabetes, glucose and lipid metabolism | multiple | ID1–2,4 | Mouse mutant models | Differentiation? |
| Osteoporosis | bone | ID1, ID4 | Mouse mutant models | Differentiation? |
| Arterial vascular disease | arteries | ID1, ID3 | Mouse mutant models | Cell cycle? |
| Congenital hydronephrosis | kidney | ID2 | Mouse mutant models | Differentiation? |
| Polycystic kidney disease | Kidney | E2A, ID2 | Gene expression | Cell cycle? |
| Parkinson’s disease | Brain, nerves | ID2 | Mouse mutant models | Differentiation? |
| Sjogren’s syndrome | Lachrymal, salivary glands, skin | ID3 | Mouse mutant models | Differentiation? |